others reflects that aging occurs at different rates. 2, 7, 8 Indeed, frailty can be a better predictor of mortality than chronological age itself. 9, 10 Understanding the mechanisms that underlie frailty is complex.
Reflecting its intrinsic relationship with aging 7 and its multiple manifestations, 11 frailty represents an accumulation of deficits across multiple systems rather than a single system impairment. Despite substantial growth in frailty research over the last two decades, there is limited understanding of the cellular and molecular processes that dictate how these deficits scale up to become clinically visible. 12 Recent emergence in the geroscience field suggests that aging occurs first at the molecular and cellular level, before becoming clinically visible in an individual. 13, 14 Building on animal models, increasingly, frailty research has focused on the assessment of subclinical frailty as a potential precursor to clinically visible frailty. 6, 13, 15 This research builds on the frailty index (FI) approach, which operationalizes frailty by calculating an index (theoretically between 0 and 1) of the proportion of health deficits present in an individual. 16 An FI built solely from vital signs and blood or urine tests (FI-Lab)
demonstrates the well-established properties of a clinical FI and has been replicated across sexes, 13 countries, 6, 13, 15, 17, 18 and species. 19, 20 FI-Lab deficits were commonly present in people with few clinically detectable health deficits; even in those with little evidence of frailty otherwise, laboratory test abnormalities increased the risk of death.
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These studies have primarily examined mortality as an outcome 13, 15, 17, 18 with limited evidence on associations with other adverse health outcomes. 6 Furthermore, most of these studies considered an older cohort, with only a single study examining these associations across the full adult life course. 13 Despite the established phenomenon of females living longer, yet experiencing higher levels of frailty, 21, 22 these studies have not examined sex differences in FI-Lab scores. For those reasons, we were interested in evaluating the relationship of abnormal laboratory test results (FI-Lab) with adverse health outcomes in a large, representative sample across the life course. Building on an initial report from our group on FILab scores and premature mortality, 13 we sought to examine if FILab scores were associated with disability, health care utilization, and self-reported health using data from the National Health and Nutrition Examination Survey (NHANES) and if these associations were present at all ages. 
| ME THODS

| Sample
| Statistical analysis
One-way analyses of variance and Tukey's post hoc examined if there were significant differences in FI scores between sexes, age groups, education levels, living status, and income categories. Logistic regressions examined the strength of the association between each FI and three adverse health outcomes: self-reported health, ADL disability, and health care utilization. Estimates represent the increased odds of having the adverse health outcome for every 0.10 increase in frailty score. Logistic regressions were performed in the full sample and then were stratified by age (ages 20-39, 40-59, 60+ years). Due to possible colinearity between the adverse health outcomes and FI-Self Report/Combined, deficits that were in both the FI and the outcome were removed from the index for their respective analyses.
All statistical analyses were conducted in SPSS 20. An alpha level of 0.05 was used to determine statistical significance.
| RE SULTS
Mean frailty scores increased with age with all three FIs ( Figure 1 ). In the FI-Self Report and FI-Combined, there was an increase in frailty across all age groups (Table 1 ; P < 0.001). In the FI-Lab, those aged 20-39 years and 40-59 years had similar scores (P = 0.31), while those aged 60+ years had significantly higher scores than both younger groups (P < 0.001). At all ages, women had higher frailty levels than men in the FI-Self Report and FI-Combined. Women aged 20-39 years had higher FI-Lab frailty than their male counterpoints, while this pattern reversed during midlife leading to men having significantly higher FI-Lab scores in those aged 60+ years (P < 0.005; Figure 1A , Table 1 ). At age 40-59 years, there were no differences in FI-Lab frailty between men and women (P = 0.85).
Those with higher levels of frailty were more likely to have lower educational attainment (P < 0.05) and income (P < 0.001); this held true in all three FIs across all age groups. There were significantly higher FI-Self Report (P < 0.001) and FI-Combined (P < 0.001) scores in those participants who were widowed (followed by divorced or separated, married, and finally not married). The same pattern was found in the FI-Lab (P < 0.01); however, there was no significant difference between those who were married and those who had never married (P = 0.59; Table 1 ). (Table 2) . FI-Self Report or FI-Combined score was also associated with higher risk of these three outcomes; these odds ratios were larger than those of FI-Lab (Table 2) . When stratified by age, FI-Lab score remained associated with higher risk of all adverse health outcomes at all ages and odds ratios were comparable between age groups. Similar patterns of association across age group were also seen for the FI-Self Report and FI-Combined (Table 2 ).
| D ISCUSS I ON
In these cross-sectional analyses, higher FI-Lab scores were associated with higher risk of poor self-reported health, disability, and high health care utilization; notably, these associations were present across all age groups. FI-Lab scores were higher in women in early life, but this pattern reversed in midlife, and men had higher FI-Lab scores after age 60 years. When compared to the FI-Self Report (and Commonly, as here with self-report data (FI-Self Report scores), women have higher frailty levels than men. 26 In contrast, the FI-Lab scores were higher in women aged 20-39 years but higher in men after age 60 years. In the Irish Longitudinal Study on Ageing, women aged 50+ years had higher scores in a self-reported FI, but lower scores in a performance-based FI, suggesting possible sex bias with self-report data. 27 Mitnitski et al 28 showed that sex differences in self-reported FIs are not consistent across all ages, and can converge in late life. Similarly, Kulminski et al 7 showed convergence of FI scores for men and women at extreme ages; they proposed that the sex-specific excess in health deficits may vary according to the particular set of potential deficits used. A related study demonstrated that abnormalities in blood pressure, pulse, cholesterol, and glucose were more strongly associated with mortality in women. 29 Even so, the so-called major health deficits (such as disability) might result in qualitatively distinctive sex deficit acceleration patterns. 30 How laboratory tests fit as major/minor deficits is not clear.
Adding more deficits to the FI can strengthen its predictive ability 31, 32 ; here, the 68-item FI-Combined showed higher odds ratios with self-reported health and health care use than did the 36-item FI-Self Report and FI-Lab. Whether this reflects the nature of the items or increased information value due to more items is not clear. 33 Similarly, Howlett et al 18 showed that combining self-reported and laboratory measures increased the prediction of mortality. In contrast, the FI-Self Report was more strongly associated with ADL disability than was the FI-Combined. This is unsurprising: a self-reported FI might be expected to be better correlated with self-reported disability in a cross-sectional study than would lab values.
These findings replicate evidence that has shown an increased risk of poor outcomes in those with higher FI-Lab score. 6, 13, 15, 17, 18 In contrast to previous analyses of this NHANES cohort with mortality, 13 the odds ratios associated with FI-Lab were smaller than those of the FI-Self Report. This may be due to the cross-sectional data collection, where one would expect clinically visible frailty to demonstrate stronger associations with the adverse health out- The main limitation of this study is the cross-sectional design.
Still, even recognizing that temporality is only one component of the Bradford Hill criteria for causation, 36 we have been careful not to make any causal claims and to comment only on associations between FI scores and three self-reported outcomes. 
TA B L E 1 Descriptive characteristics of the full sample by all three frailty indices
The FI-Lab could be utilized as an early screening tool to identify those exhibiting patterns of frailty at the cellular/molecular level.
Indeed, creating an FI-Lab using routine blood tests could be a more convenient and feasible option to identify those at increased risk, as recently shown by the electronic FI (e-FI), which calculates a frailty score using routinely available, primary care health records. 37 Clinically visible deficits must arise as a consequence of what is happening at the organ, tissue, and cellular/subcellular levels.
Exactly how subcellular deficits scale up to become clinically visible
is not yet clear. 38, 39 Linking FI-Lab changes to single aging biomarkers is proving to be tricky, as proven by experience with it and telomere length. 14, 40, 41 Some results suggest that the degree of frailty correlates with structural and functional changes at the cellular and organ levels. 42, 43 In general, these changes suggest that how subcellular changes occur influences the propagation of deficits through a complex network.
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